Results of two Phase II trials of LT3001 for the treatment of acute ischemic stroke
Автор: VJNeurology
Загружено: 2026-02-16
Просмотров: 13
Описание:
Thomas Devlin, MD, PhD, FSVIN, CommonSpirit Memorial Neuroscience Institute, Chattanooga, TN, discusses the results of two international Phase II studies (NCT05686642, NCT05403866) evaluating the safety and efficacy of LT3001 in the treatment of acute ischemic stroke. Dr Devlin reports promising findings, and notes that the results of these studies will inform the design of a pivotal international Phase III study. This interview took place at the 2026 International Stroke Congress (ISC), held in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: